The conference programme will feature keynote addresses, case study presentations, panel and roundtable discussions from over 45 speakers in Biomarker Discovery and Validation, Molecular Diagnostics, Data Integration, Modelling and Bioinformatics, Imaging, Clinical Development and Enabling Technologies including:

Nicholas Dracopoli, Vice President, Biomarkers, Centocor Research & Development

Duncan McHale, Vice President,  Medical Director Personalized Healthcare, AstraZeneca

Francis Kalush, Network Leader for the Diagnostics (In vivo and In Vitro) and Personalized Medicine Network, FDA

Miro Venturi, Director Biomarkers and Experimental Medicine, F. Hoffmann La Roche

Mark Jones, Associate Director Molecular Biomarkers, UCB Group

David Reynolds, Senior Director, Experimental Biological Sciences, Pfizer

Roly Foulkes, Vice President Inflammation, UCB

Martina Kaufmann, Biomarker Project Leader, Head Oncology Biomarkers & Imaging, Novartis

Huseyin Mehmet, Director Exploratory Biomarkers, Diabetes, Merck Research Laboratories

Alison Banham, Nuffield Department of Clinical Laboratory Sciences, Oxford University

Sanja Selek, Head of Serology and Immune Assays Department, InterCell AG

Simon Read, Leader Biomarker and Experimental Medicine, F. Hoffmann-La Roche

Matt Squires, Associate Director Translational Biology, Astex Therapeutics

Early bird discount is available by quoting “BIOMDEL01”. For information on sponsorship and delegate attendance email info@oxfordglobal.co.uk or call +44(0) 1865 304925. www.biomarkers-congress.com.